Colgate-Palmolive Company

🇺🇸New York Stock Exchange

Articles

34
Show Summary
Show Bulletpoints
Detailed View
Somewhat Bullish +35

Colgate Stock Rises 17% in 6 Months: Buy or Wait for a Pullback?

📈 CL shares rose 16.9% in six months, outpacing sector and S&P 500 gains.

🚀 Organic sales growth accelerated in Q1 2026 across all product categories.

💡 Company investing in AI and digital capabilities to improve marketing efficiency.

⚠️ Management lowered full-year gross margin outlook due to $300 million inflation costs.

📉 North America faces delays, promotions, and tariff pressures as weakest region.

📈 CL shares rose 16.9% in six months, outpacing the Consumer Staples sector's 9.5% gain and the S&P 500's 7.3% rise.

🚀 Organic sales growth accelerated in Q1 2026 due to stronger volume trends across all four product categories and four of five geographic divisions.

💡 The company is investing in AI, data analytics, and digital capabilities to improve marketing efficiency and consumer targeting.

🌍 Emerging markets, particularly Asia Pacific and Latin America, delivered meaningful volume growth acceleration supported by innovation.

🐾 Hill's Pet Nutrition remains a solid growth engine with organic sales growth despite a soft overall pet food market.

⚠️ Management lowered the full-year gross margin outlook due to approximately $300 million in additional inflationary costs for 2026.

📉 North America is identified as the weakest operating region facing delayed launches, competitive promotions, and tariff pressures.

💰 Colgate trades at a premium forward P/E of 23.54 versus the industry average of 18.42, suggesting limited room for multiple expansion.

🛑 Analysts maintain a Zacks Rank #3 (Hold) rating, advising new investors to wait for a more favorable entry point.

Bullish Signals
  • CL shares up 16.9% vs S&P 500's 7.3% gain.
  • Organic sales growth accelerated in Q1 2026.
  • Investments in AI enhance marketing efficiency and ROAS.
  • Solid organic growth reinforces segment long-term potential.
  • Asia Pacific and Latin America volume growth accelerating.
Risk Factors
  • Colgate lowered 2026 gross margin outlook due to $300M inflationary costs.
  • North America remains weakest region facing delays, competition, and tariff pressures.
  • Stock trades at premium forward P/E of 23.54 vs industry average 18.42.
  • Higher oil-based inputs driving increased costs weighing on profitability.
Bullish Signals
  • CL shares have appreciated 16.9% in the past six months, significantly outperforming the industry's 3.2% return and the S&P 500's 7.3% gain.
  • Organic sales growth accelerated in Q1 2026, supported by stronger volume trends across all four product categories and four of five geographic divisions.
  • The company is successfully executing an innovation-led growth strategy with investments in AI and digital capabilities enhancing marketing efficiency and return on advertising spend.
  • Hill's Pet Nutrition delivered solid organic sales growth despite a soft market, reinforcing confidence in the segment's long-term potential.
  • Asia Pacific and Latin America regions posted meaningful volume growth acceleration driven by innovation and strong in-store performance.
Risk Factors
  • Colgate lowered its full-year gross margin outlook for 2026 due to approximately $300 million in additional inflationary costs from raw materials, packaging, and logistics.
  • North America remains the weakest operating region, facing delayed product launches, an increasingly competitive promotional environment, and tariff-related pressures.
  • The stock trades at a premium forward P/E of 23.54 compared to the industry average of 18.42, indicating that much of the near-term optimism may already be priced in.
  • Higher oil-based inputs such as resins, petrochemicals, fats, and oils are driving increased costs that could weigh on profitability until strategic interventions deliver results.
Somewhat Bullish +45

Colgate-Palmolive holds firm ahead of next earnings, S&P 500 stock in analyst focus - Ad-hoc-news.de

📈 Analysts expect continued revenue growth and solid EPS in the upcoming quarter.

💰 Stock recently traded at $89.78 USD with premium peer valuation.

📊 Trailing P/E ratio is approximately 34 based on $2.61 EPS.

🏢 MarketBeat lists it as a core S&P 500 consumer sector holding.

🛒 Revenue driven globally by oral care products like toothpaste and brushes.

📈 Analysts expect Colgate-Palmolive to post continued year-on-year revenue growth and solid earnings per share in the upcoming quarter.

💰 The stock recently traded at $89.78 USD, reflecting a valuation consistent with premium consumer staples peers.

📊 The company maintains a trailing price-to-earnings ratio of approximately 34 based on EPS of $2.61.

🏢 MarketBeat data highlights the stock's status as a core holding in the S&P 500 consumer sector.

🛒 Revenue is primarily driven by oral care products like Colgate toothpaste and toothbrushes sold globally.

📅 The next quarterly earnings report date has not been officially scheduled yet.

🌍 Products are distributed through supermarkets, drugstores, and online channels worldwide.

Bullish Signals
  • Analysts project continued organic sales growth and margin resilience.
  • Defensive stock with steady demand for everyday products.
  • Valuation aligns with premium peers indicating stable cash flows.
Bullish Signals
  • Analysts project continued organic sales growth and margin resilience for the company ahead of the next earnings report.
  • The stock is viewed as a defensive play within the consumer sector due to steady demand for everyday products.
  • Valuation multiples align with premium peers, suggesting confidence in stable cash flows and market position.
Slightly Bullish +25

Colgate-Palmolive Stock - Weekly outlook with next earnings on the radar - Ad-hoc-news.de

📅 Reports quarterly in late July or October; 2026 date unconfirmed.

💰 Trades at mid-30s trailing P/E multiple based on TTM earnings.

📈 Analysts expect mid-single-digit organic sales growth and margin progress.

🏢 Market cap approx $72 billion as of June 22, 2026.

📉 Shares trade on NYSE at roughly $89.03 as of June 22, 2026.

📅 Colgate-Palmolive typically reports quarterly results in late July or late October, with the exact next date for 2026 not yet officially scheduled.

💰 The stock trades at a trailing price-to-earnings multiple in the mid-30s based on trailing twelve-month earnings per share.

📈 Analyst consensus expects steady mid-single-digit organic sales growth and incremental margin progress over the coming quarters.

🏢 The company holds a market capitalization of approximately $72 billion as of June 22, 2026.

📉 Shares trade on the New York Stock Exchange at roughly $89.03 as of June 22, 2026.

🦷 Revenue is primarily driven by oral care products led by the global Colgate toothpaste and toothbrush franchise.

🏠 Additional revenue streams include home care brands like Palmolive and Protex, plus pet nutrition under Hill's.

📊 The company is a member of the Standard & Poor's 500 index within the Consumer Staples sector.

🌍 Management will provide updates on volumes, pricing, and margins across North America, Latin America, Europe, and Asia-Pacific.

💼 Market data providers track the upcoming report window based on historical patterns despite the lack of a formal calendar posting.

Bullish Signals
  • Analysts expect steady mid-single-digit organic sales growth.
  • Stock trades at trailing P/E multiple in mid-30s.
  • Management continues ongoing share repurchases like prior years.
  • Revenue from diverse categories including oral care.
Bullish Signals
  • Analyst consensus expects steady mid-single-digit organic sales growth over the coming quarters.
  • The stock trades at a trailing price-to-earnings multiple in the mid-30s, embedding expectations for continued pricing power and disciplined cost control.
  • Management is expected to continue ongoing share repurchases in line with prior years.
  • The company maintains a resilient business profile with revenue from diverse categories including oral care, home care, and pet nutrition.
Slightly Bullish +15

Procter & Gamble vs. Colgate-Palmolive: One Dividend Giant Stands Above the Rest - 24/7 Wall St.

📊 P&G Q3 core EPS hit $1.59 on $21.2B sales with Beauty up 11%.

🦷 Colgate Q1 adjusted EPS reached $0.97 as Oral and Home Care rose 8.9%.

📉 P&G gross margin slipped 100 bps due to $400M tariff drag and commodity costs.

🔄 Colgate launched a program with $350-$550M charges targeting $200-$300M annual savings.

📈 P&G repurchased over $600M in shares with $5B planned for fiscal 2026.

📊 P&G reported fiscal Q3 2026 core EPS of $1.59 on net sales of $21.235 billion, driven by 11% growth in Beauty and 7% in Grooming.

🦷 Colgate-Palmolive posted Q1 2026 adjusted EPS of $0.97 on revenue of $5.324 billion, with Oral, Personal, and Home Care rising 8.9%.

📉 P&G's core gross margin slipped 100 basis points due to roughly $400 million in after-tax tariff drag and $150 million in commodity headwinds.

🔄 Colgate is executing a Strategic Growth and Productivity Program with pretax charges of $350 million to $550 million targeting annual savings of $200 million to $300 million.

📈 P&G repurchased over $600 million in shares during Q3 with roughly $5 billion planned for fiscal year 2026.

💰 Colgate increased its dividend to $0.53 per share, though the stock trades at a premium of 35x trailing earnings.

🌍 P&G achieved broad-based growth across product categories and regions, with Fabric & Home Care delivering $7.403 billion in sales.

📉 Colgate's North America organic sales declined 1.8% with volume off 3.2%, representing a key area of concern for investors.

🐾 Hill's Pet Nutrition added $1.194 billion in revenue for Colgate, identified as the cleanest growth lane in the company's portfolio.

📈 P&G's 10-year total price return stands at 141.11%, supported by a 136-year dividend payment streak and deep free cash flow generation.

Bullish Signals
  • Beauty grew 11% and Grooming added 7%.
  • Oral Care rose 8.9% to $4.131 billion.
  • Hill's added $1.194 billion in revenue.
  • Repurchased over $600 million in Q3 shares.
  • Increased dividend to $0.53 per share.
Risk Factors
  • P&G gross margin slipped 100 bps due to $400M tariff drag.
  • Colgate North America organic sales declined 1.8% with volume off 3.2%.
  • Colgate faces $350M-$550M pretax charges under its Strategic Growth Program.
  • Gross margin guidance revised lower due to tariffs impacting profitability.
  • Advertising spend rose to $734M from $668M indicating marketing pressure.
Bullish Signals
  • P&G demonstrated broad-based growth across product categories and regions, with Beauty growing 11% and Grooming adding 7%.
  • Colgate's Oral, Personal, and Home Care segments rose 8.9% to $4.131 billion, showing resilience in core businesses.
  • Hill's Pet Nutrition added $1.194 billion in revenue for Colgate, providing a clean growth lane amidst other challenges.
  • P&G repurchased over $600 million in shares during Q3 with roughly $5 billion planned for fiscal year 2026, signaling confidence.
  • Colgate recently increased its dividend to $0.53 per share, demonstrating commitment to shareholder returns despite restructuring costs.
Risk Factors
  • P&G's core gross margin slipped 100 basis points due to roughly $400 million in after-tax tariff drag and $150 million in commodity headwinds.
  • Colgate's North America organic sales declined 1.8% with volume off 3.2%, indicating a sore spot for the company's core business.
  • Colgate faces pretax charges of $350 million to $550 million under its Strategic Growth and Productivity Program, increasing short-term costs.
  • Colgate's gross margin guidance was revised lower because of tariffs, impacting future profitability expectations.
  • Colgate's advertising spend rose to $734 million from $668 million, indicating increased marketing pressure in a difficult operating environment.
Somewhat Bullish +50

Colgate-Palmolive Stock (US1941621039): Bernstein initiates coverage with fresh price target focus - AD HOC NEWS

📈 Bernstein initiates Colgate-Palmolive with a $96 price target.

💰 Current stock at $77.72 offers upside to the analyst target.

📊 Company reported a 21% operating margin in the last quarter.

🛡️ Stock viewed as a defensive play for stability and dividends.

🦷 Core revenue driven by branded oral-care products globally.

📈 Bernstein initiates coverage on Colgate-Palmolive with a fresh price target of $96.

💰 Current stock price is quoted at $77.72, suggesting upside potential to the analyst target.

📊 Company reported an operating margin of 21% in its last reported quarter.

🆚 Operating margin trails Procter & Gamble by approximately 4 percentage points.

🌍 Colgate-Palmolive operates globally with key positions in North America, Latin America, Europe, and Asia.

🦷 Core revenue drivers include branded oral-care products like toothpaste and toothbrushes.

🛡️ The stock is viewed as a defensive play appealing to investors seeking stability during macro uncertainty.

📉 Analysts see potential for margin catch-up through premiumization and efficiency gains.

💸 Capital-return policies including dividends and share repurchases are key valuation metrics.

🏢 Headquarters located in New York, New York, United States.

Bullish Signals
  • Bernstein initiates with $96 price target, implying upside from $77.72.
  • Resilient earnings base driven by global oral care brand strength.
  • Defensive staple suitable for core portfolio positions during market stress.
  • Robust margins maintained despite elevated raw-material prices and supply disruptions.
  • Potential value creation through narrowing margin gap with peers.
Risk Factors
  • Operating margin of 21% lags competitor Procter & Gamble by 4 percentage points.
  • Valuation multiples may be constrained if market perceives limited forward earnings growth potential.
  • Currency exposure and competitive dynamics in key markets could impact organic sales growth.
Bullish Signals
  • Bernstein initiates coverage with a $96 price target, implying upside from the current quoted price of $77.72.
  • The company maintains a resilient earnings base driven by global brand strength in oral care products.
  • Analysts view the stock as a defensive staple suitable for core portfolio positions during market stress.
  • Colgate-Palmolive has maintained robust margins despite elevated raw-material prices and supply-chain disruptions.
  • There is potential for incremental value creation through narrowing the margin gap with peers like Procter & Gamble.
Risk Factors
  • Operating margin of 21% lags behind competitor Procter & Gamble by roughly 4 percentage points.
  • Valuation multiples may be constrained if the market perceives limited forward earnings growth potential.
  • Currency exposure and competitive dynamics in key markets could impact organic sales growth.
Somewhat Bullish +50

Colgate-Palmolive renews University’s oldest business partnership

🤝 Colgate-Palmolive renews £2m funding for its historic 1968 Manchester research partnership.

🔬 Extended funds support clinical research and a new European fellowship program.

🌍 The collaboration serves as a global model for advancing oral health policy.

🤝 Colgate-Palmolive is renewing its £2 million funding commitment to extend its research partnership with The University of Manchester.

🦷 This collaboration supports the Dental Health Unit (DHU), which has been a leading center for oral health research for nearly 60 years.

📜 The partnership dates back to 1968, making it the longest-standing business relationship in the University's history.

🏭 Colgate-Palmolive maintains historic ties to Manchester through its former factory in Salford Quays, now known as Soapworks.

🌍 The company sells its health and hygiene products in over 200 countries and territories worldwide.

🔬 The funding extension will support high-quality clinical and behavioral research to generate real-world evidence for policy and practice.

🎓 A Fellowship Program will be launched to train the next generation of oral health researchers across Europe and North America.

👩‍🏫 Professor Anne-Marie Glenny stated the partnership has reaped real health impacts over 50 years while developing research leaders.

🚀 The DHU aims to expand its PhD program across renowned universities in the UK, Europe, and North America.

🧠 Professor Jan Clarkson highlighted the goal of establishing the DHU as a strategic hub for advancing oral health behavior change.

🌐 Maria Ryan, Colgate-Palmolive's Executive Vice President Chief Clinical Officer, praised the DHU as a pioneer breaking down silos between academia and industry.

🏆 The collaboration serves as a global model, with similar Dental Health Units now based in Latin America and India.

🎯 The initiative leverages behavioral insights to deliver impactful, scalable outcomes that improve public health policies globally.

🤝 This private-public collaboration combines industry and academic expertise to drive international excellence in scientific innovation.

❤️ Colgate-Palmolive's purpose is to reimagine a healthier future for all people, their pets, and the planet.

Bullish Signals
  • Colgate-Palmolive funds £2M Manchester research partnership extension.
  • Company reaffirms global leadership in toothpaste and brushes.
  • Funding supports clinical research for real-world policy evidence.
  • Partnership enables Fellowship Program for early career researchers.
  • 50-year collaboration delivers world-leading oral health impacts.
Risk Factors
  • No negative aspects or risks identified in the provided text.
Bullish Signals
  • Colgate-Palmolive is committing to fund a £2 million extension of its long-standing research partnership with The University of Manchester.
  • The company, which sells products in more than 200 countries and territories, reaffirms its status as the global leader in toothpaste and manual toothbrushes.
  • This funding will support high-quality clinical and behavioural research to generate real-world evidence for policy and practice.
  • The extension allows the Dental Health Unit to run a Fellowship Program, with the first awards already announced for early career researchers in Europe and North America.
  • The partnership has reaped real health impacts over 50 years, carrying out world-leading oral health research and supporting the development of research and policy leaders.
  • The collaboration aims to strategically expand the PhD program across renowned universities throughout the UK, Europe, and North America.
  • The DHU is being established as a strategic hub for advancing oral health behaviour change and delivering impactful, scalable outcomes that improve public health policies globally.
Risk Factors
  • The article contains no negative aspects or risks; it exclusively details a positive partnership renewal, funding commitment, and research expansion between Colgate-Palmolive and the University of Manchester.
Somewhat Bearish -25

Colgate Palmolive India Q1 Results: Net profit dips 11.8% to Rs 321 crore

📉 Net profit fell 11.8% to Rs 321 crore in Q1FY26.

💰 EBITDA dropped 11% to Rs 453 crore from last year.

📉 Sales and operating margins declined by 4.4% and 240 bps respectively.

📉 Colgate Palmolive India reported a net profit of Rs 321 crore for Q1FY26, marking an 11.8% year-on-year decline from Rs 364 crore in the same period last year.

📉 Net sales fell by 4.4% to Rs 1,421 crore compared to Rs 1,486 crore in Q1FY25, while revenue from operations also dropped 4.3% to Rs 1,433 crore.

💰 EBITDA decreased by 11% to Rs 453 crore, down from Rs 508.34 crore recorded during the first quarter of the previous fiscal year.

📉 Operating margins narrowed significantly to 31.6% from 34% in the year-ago period, representing a contraction of 240 basis points.

📅 The company declared its financial performance for the first quarter of FY26 on Tuesday, July 22.

Bullish Signals
  • Colgate Palmolive India Q1 FY26 net profit: Rs 321 crore.
  • Company maintained profitability despite market headwinds.
Risk Factors
  • Net profit declined 11.8% to Rs 321 crore.
  • Net sales fell 4.4% to Rs 1,421 crore.
  • Revenue from operations dropped 4.3% to Rs 1,433 crore.
  • Operating margins contracted 240 bps to 31.6%.
  • EBITDA fell 11% to Rs 453 crore.
Bullish Signals
  • Colgate Palmolive India declared its financial performance for the first quarter of FY26 on Tuesday (July 22).
  • The company reported a net profit of Rs 321 crore, demonstrating continued profitability despite market headwinds.
Risk Factors
  • Net profit declined 11.8% year-on-year to Rs 321 crore from Rs 364 crore in Q1FY25.
  • Net sales fell by 4.4% to Rs 1,421 crore compared to Rs 1,486 crore in the same period last year.
  • Revenue from operations decreased by 4.3% to Rs 1,433 crore versus Rs 1,496.71 crore in Q1FY25.
  • Operating margins contracted significantly to 31.6% from 34%, representing a 240 basis point decline.
  • EBITDA fell by 11% to Rs 453 crore down from Rs 508.34 crore in Q1FY24.
Slightly Bullish +25

Colgate-Palmolive India raises toothpaste prices amid rising input costs

📈 Colgate India raised toothpaste prices by 4-5% due to rising input costs.

🧴 Dental Cream packs now offer nearly 10% more content at higher prices.

💰 Toothpaste drives 80% of revenue, while mass-market low-priced packs stay unchanged.

📈 Colgate-Palmolive India has increased prices on several toothpaste products by 4-5% this month due to rising input costs.

📦 Specific price hikes include the Colgate Dental Cream combo pack rising from Rs 200 to Rs 208 and the standalone 200g pack increasing to Rs 135.

🧴 The company has increased the price of the 100g Colgate Dental Cream pack by Rs 3 while simultaneously boosting its content by nearly 10%.

💎 Premium variants like Visible White Purple saw sharper hikes, with the 200g pack's MRP jumping to Rs 395 from a lower base.

📉 Low-priced packs are unlikely to see immediate revisions as they target highly price-sensitive mass-market consumers.

🏭 The price adjustments reflect broader inflationary trends affecting raw materials, packaging, and logistics in the FMCG sector.

💰 Toothpaste remains the company's largest revenue segment, contributing approximately 80% of Colgate-Palmolive India's total business revenue.

📊 Shares of Colgate-Palmolive India traded largely unchanged on Friday, closing around Rs 2,083 on the National Stock Exchange.

Bullish Signals
  • Toothpaste drives nearly 80% of Colgate-Palmolive India revenue.
  • 100g Dental Cream gained 10% grammage despite price hike.
  • Visible White Purple 200g pack offers 20% extra content.
  • Max Fresh Blue 70g pack includes 15% extra content.
Risk Factors
  • Colgate-Palmolive India hikes prices 4-5% due to rising costs.
  • Low-priced packs excluded from hikes, limiting 80% revenue segment growth.
Bullish Signals
  • Toothpaste remains the company's largest revenue-generating segment, contributing nearly 80 per cent of Colgate-Palmolive India's overall business revenue.
  • The company has simultaneously increased the product grammage by nearly 10 per cent in the 100g Colgate Dental Cream category despite the price increase.
  • Premium toothpaste variants have witnessed content enhancements, such as the Visible White Purple 200g pack featuring 20 per cent extra content.
  • The Colgate Max Fresh Blue 70g pack includes 15 per cent extra content alongside its price revision.
Risk Factors
  • Colgate-Palmolive India has increased prices on several toothpaste products with hikes ranging between 4% and 5%, driven by continued pressure from rising raw material, packaging, and logistics costs.
  • The company indicated that low-priced packs are unlikely to see immediate revisions as they cater to highly price-sensitive mass-market consumers, potentially limiting growth in the largest revenue segment which contributes nearly 80% of overall business revenue.
Slightly Bullish +25

Is Colgate Too Dependent on Pricing Actions for Revenue Growth?

📈 CL shares rose 11.7% vs industry decline in six months.

🌏 Asia Pacific and Latin America drove strong volume gains.

💰 Pricing actions protect margins while balancing volume growth.

🔭 Analysts forecast 3.5% earnings growth for fiscal 2026.

📉 Stock trades at a premium P/E with a Sell rating.

📈 Colgate-Palmolive (CL) shares have gained 11.7% over the past six months, contrasting with an industry decline of 4.5%.

📊 The company achieved volume and pricing growth across all four categories in four of its five operating divisions for Q1 fiscal 2026.

🌏 Volume performance improved significantly in the Asia Pacific region, which management views as a primary growth engine.

🇧🇷 Latin America continued to deliver solid volume performance and market share gains during the quarter.

💰 Pricing actions remain critical for protecting margins and supporting category investment amid inflationary pressures.

🚀 Future pricing initiatives will increasingly be supported by innovation and strong value propositions across multiple price points.

📉 Industry-wide category volumes remain relatively sluggish globally, making Colgate's recent acceleration particularly encouraging.

📈 The company is striving to balance volume and pricing rather than relying solely on price increases for revenue growth.

🔭 Zacks Consensus Estimates imply year-over-year earnings growth of 3.5% for 2026 and 5.6% for 2027.

💸 CL trades at a forward P/E ratio of 23X, which is higher than the industry average of 17.68X.

📉 The stock currently carries a Zacks Rank #4 (Sell) rating.

🏢 Colgate appears increasingly balanced between pricing and volume growth to support sustainable revenue expansion.

Bullish Signals
  • Colgate-Palmolive achieved volume/pricing growth in Q1 fiscal 2026.
  • Asia Pacific drove improved volume performance as a growth engine.
  • Emerging markets delivered solid volume despite sluggish global category volumes.
  • Shares gained 11.7% vs industry decline of 4.5%.
  • Future pricing supported by innovation for sustainable revenue growth.
Risk Factors
  • Colgate trades at 23X forward P/E vs 17.68X industry average.
  • Stock carries a Zacks Rank #4 (Sell) rating.
Bullish Signals
  • Colgate-Palmolive achieved broad-based volume and pricing growth across all four categories and four of its five operating divisions in the first quarter of fiscal 2026.
  • The company demonstrated improved volume performance, particularly within the Asia Pacific region, which management views as a primary growth engine.
  • Emerging markets, including Latin America, continued delivering solid volume performance and market share gains despite sluggish global category volumes.
  • Colgate's shares have gained 11.7% in the past six months, significantly outperforming the industry's decline of 4.5%.
  • Future pricing initiatives will increasingly be supported by innovation and strong value propositions across multiple price points to drive sustainable revenue growth.
Risk Factors
  • Colgate trades at a forward price-to-earnings ratio of 23X, which is significantly higher than the industry average of 17.68X.
  • The stock carries a Zacks Rank #4 (Sell) rating.
Neutral +5

Colgate-Palmolive Shareholders Back Board, Pay Practices, Auditor

✅ Shareholders ratified board elections, CEO appointment, and auditor selection at the May 2026 meeting.

❌ Governance proposals to remove DEI or adopt an independent chair failed this year.

📉 Analysts rate the stock a Hold with an $80 price target amid rising margin pressure.

🗳️ Colgate-Palmolive shareholders successfully ratified the board of directors, CEO Noel Wallace's election, and the appointment of PricewaterhouseCoopers as auditor at the May 8, 2026 annual meeting.

👥 Investors approved the non-binding advisory vote on executive compensation, indicating continued support for current pay practices.

❌ Two shareholder proposals aimed at governance changes failed: one sought to remove DEI considerations from board selection, while another called for an independent board chair.

💰 Analysts currently rate Colgate-Palmolive stock as a Hold with a price target of $80.00.

📉 Spark AI classifies the stock as Neutral due to strong profitability and cash flow resilience offset by elevated balance-sheet risk and thin equity.

📊 The company's earnings call showed maintained guidance but noted rising margin pressure, contributing to modest technical support.

💵 Valuation remains challenged by a negative P/E ratio despite a reasonable dividend yield.

🌍 Colgate-Palmolive operates globally across oral care, personal care, home care, and pet nutrition categories in both developed and emerging markets.

Bullish Signals
  • Colgate shareholders elected ten directors on May 8, 2026.
  • PricewaterhouseCoopers ratified as auditor for fiscal year ending Dec 31, 2026.
  • Investors approved executive compensation advisory vote signaling continued support.
  • DEI and independent chair proposals rejected reinforcing governance structure.
  • Strong profitability and cash flow drive positive stock analysis.
Risk Factors
  • Hold rating with $80 price target lacks bullish momentum.
  • High leverage and thin equity create material balance-sheet risk.
  • Rising margin pressure signals deteriorating profitability trends.
  • Modest technical signals fail to support strong price gains.
  • Poor P/E ratio negatively impacts overall stock valuation.
Bullish Signals
  • Colgate-Palmolive shareholders elected ten directors at the annual meeting on May 8, 2026, demonstrating strong confidence in current leadership.
  • Shareholders ratified the appointment of PricewaterhouseCoopers LLP as the independent auditor for the fiscal year ending December 31, 2026, reinforcing financial oversight standards.
  • Investors approved the non-binding advisory vote on executive compensation, signaling continued support for the company's pay practices and management strategy.
  • Shareholders rejected two shareholder proposals to remove DEI considerations or establish an independent board chair, which reinforced the company's existing governance framework and board oversight structure.
  • The stock analysis score is driven primarily by strong profitability and cash flow resilience.
Risk Factors
  • Analyst ratings on Colgate-Palmolive stock remain at a Hold with an $80.00 price target, indicating lack of bullish momentum.
  • The company faces material balance-sheet risk characterized by thin equity and very high reported leverage which constrains overall performance metrics.
  • Earnings guidance held steady while margin pressure is rising, suggesting deteriorating profitability trends despite mixed results.
  • Technical signals for the stock are only modestly supportive, failing to indicate strong upward price momentum.
  • The company's valuation is negatively impacted by a poor P/E ratio, even though it maintains a reasonable dividend yield.
  • Shareholders rejected proposals for an independent board chair and removing DEI considerations, reinforcing the existing governance framework which may not satisfy all activist investors.
Bullish +75

Prediction: Colgate-Palmolive Will Jump 20% This Year

📈 Analysts target a 17.99% share gain with a $103.17 price prediction.

🛡️ Strong defense features include low volatility, resilient brands, and rising dividends.

🚀 Q1 earnings beat estimates while international growth offsets North American declines.

📈 Analysts project Colgate-Palmolive shares to gain 17.99% in the next 12 months, with a price target of $103.17 compared to current levels around $87.44.

🛡️ Investors view the stock as defensive due to its low beta (0.3), 63-year dividend streak, and resilient brand portfolio during economic downturns.

📊 Q1 2026 earnings beat analyst estimates with adjusted EPS of $0.97 versus consensus of $0.9445, extending a streak of four consecutive quarters of positive surprises.

🌍 Revenue growth was driven by international markets, with Latin America up 14.8% and Europe up 11.9%, partially offsetting a -1.8% decline in North American revenue.

💰 Free cash flow surged 27.94% to $609 million in Q1, while operating cash flow increased 24.5%, highlighting strong underlying liquidity generation.

📈 Organic sales growth is accelerating significantly from 0.4% in Q3 2025 to 2.9% in Q1 2026, with emerging markets specifically up 6.2%.

💵 The company raised its quarterly dividend to $0.53, marking the 63rd consecutive annual increase for shareholders.

🔧 SGPP restructuring aims to deliver $200-$300 million in annual pretax savings to fund advertising and recover margins once tariff pressures ease.

⚠️ Tariffs remain a key headwind, causing management to revise 2026 GAAP gross margin guidance downward due to the evolving geopolitical landscape.

📉 North America organic sales declined 2.2% in Q1, reflecting ongoing challenges in the domestic market despite global strength.

💸 A $919 million goodwill impairment related to the Filorga skin health business occurred in Q4 2025 due to weakness in the Chinese market.

📉 Current valuation reflects the goodwill charge with a trailing P/E of 34, though forward P/E drops to a more reasonable 23x.

🐻 Even in a bear-case scenario accounting for risks like tariff escalation, the projected downside is limited by the stock's low-beta and dividend yield.

🚀 Our bull-case scenario projects a total return of 22.99%, reaching a price target of $107.54 if current growth and margin trajectories hold.

🎯 Wall Street consensus includes 13 buy or strong buy ratings against zero sells, with an average price target of $96.00.

🤖 Long-term success depends on executing the 2030 strategy and reaching the high end of savings guidance from the SGPP program.

⚡ The setup favors low-volatility compounding growth for investors seeking stability in a murky macroeconomic environment.

🧨 Key risks to monitor include further tariff escalations beyond consumer staples and continued deterioration in North America volumes.

Bullish Signals
  • Price target $103.17 implies 17.99% upside.
  • Rated buy with 90% confidence.
  • Shares up 12.04% year to date.
  • Earnings beat extended streak to four quarters.
  • Revenue grew 8.4% driven by emerging markets.
Risk Factors
  • Management lowered 2026 gross margin guidance due to tariffs.
  • North America organic sales dropped -1.8% in Q1, projecting -2.2%.
  • Colgate recorded $919 million goodwill impairment for China weakness.
  • Trailing P/E of 34 exposes stock to significant downside risk.
Bullish Signals
  • Our 24/7 Wall St. price target for Colgate-Palmolive is $103.17 over the next 12 months, implying 17.99% upside from current levels.
  • We rate the stock a buy with 90% confidence based on its strong defensive characteristics.
  • The stock has gained momentum with shares up 12.04% year to date and 4.33% over the past month, recovering from previous lows.
  • Q1 2026 adjusted earnings of $0.97 beat consensus estimates of $0.9445, extending a beat streak to four straight quarters.
  • Revenue grew 8.4% year-over-year to $5.324 billion, with Latin America surging 14.8% and Europe up 11.9%.
  • Free cash flow jumped significantly by 27.94% to $609 million in the first quarter.
  • Organic sales growth is accelerating from 0.4% in Q3 2025 to 2.9% in Q1 2026, with emerging markets up 6.2%.
  • The company's SGPP restructuring program targets $200-$300 million in annual pretax savings to fund growth initiatives.
  • Colgate maintains a robust dividend streak of 63 consecutive annual increases, with the most recent step-up to $0.53 per quarter.
  • Wall Street consensus includes 13 buy or strong buy ratings and zero sells, highlighting broad analyst support.
  • The forward P/E of 23 is viewed as more attractive than the trailing multiple due to one-time charges from goodwill impairments.
  • Operating cash flow grew 24.5% in Q1, demonstrating underlying financial strength despite macro headwinds.
Risk Factors
  • Management revised 2026 GAAP gross margin guidance from up to down due to the evolving tariff environment.
  • North America organic sales declined -1.8% in Q1, with a broader bear-case scenario indicating a -2.2% decline for the period.
  • Colgate recorded a $919 million goodwill impairment in Q4 2025 associated with weakness in its China market.
  • A trailing P/E of 34 leaves little room for execution slippage, exposing the stock to significant downside risk.
  • Key risks include potential tariff escalation broadening beyond consumer staples and further deterioration in North America volumes.
Bullish +70

Colgate-Palmolive’s Q1 Earnings Call: Our Top 5 Analyst Questions

📈 Q1 2026 revenue hit $5.32B, beating estimates with 8.4% annual growth.

💰 Adjusted EPS of $0.97 exceeded forecasts by 2.7%.

🛡️ Operating margins fell to 18.1% despite strong top-line sales.

🌏 Asia Pacific and India drove broad-based regional expansion.

⚠️ Management faces margin headwinds from rising raw material costs.

📈 Colgate-Palmolive reported Q1 2026 revenue of $5.32 billion, surpassing Wall Street estimates of $5.23 billion with 8.4% year-on-year growth.

💰 Adjusted EPS reached $0.97 compared to analyst expectations of $0.94, representing a 2.7% positive surprise.

🛡️ Operating margins declined to 18.1% from 21.9% in the prior year quarter despite strong top-line performance.

🌏 Emerging markets, particularly Asia Pacific and India, were credited with driving broad-based growth through successful interventions and innovation.

💸 Raw material costs increased by $300 million, primarily due to rising oil-based input prices impacting the company's cost structure.

📉 Organic revenue growth was measured at 2.9% year on year, which beat analyst expectations while sales volumes rose 1.1%.

🗣️ CEO Noel Wallace emphasized strategic resets for North America to address volume challenges and improve market share.

🇨🇳 Performance in China and India was highlighted as critical factors driving growth in the Asia Pacific region through digital execution.

📉 Analysts expressed concern about gross margin headwinds, with management expecting lower margins throughout the fiscal year despite pricing strategies.

🤖 CFO Stanley Sutula noted that productivity enhancements and pricing actions are key mitigation strategies against inflationary pressures.

🚀 Management highlighted late-quarter innovation in the U.S. Oral Care segment as a catalyst for expected sequential gains.

⏭️ Investors will be watching emerging market momentum persistence, North America strategy effectiveness, and cost inflation offsetting capabilities in future quarters.

Bullish Signals
  • Revenue beat expectations with $5.32 billion.
  • Adjusted EPS rose to $0.97 versus $0.94.
  • Emerging markets acceleration drives broad growth.
  • Hawley & Hazel interventions fuel momentum.
  • Sales volumes increased 1.1% year-on-year.
  • Organic revenue grew by 2.9%.
  • Asian markets supported by innovation and digital.
Risk Factors
  • Margins contracted from 21.9% to 18.1% amid inflation.
  • $300M cost rise requires productivity offsets and pricing action.
  • Gross margin guidance lowered despite mitigation efforts.
  • North American volume growth lags emerging markets significantly.
  • U.S. Oral Care segment faces sustained competition pressure.
  • Emerging market volume sustainability remains under analyst scrutiny.
Bullish Signals
  • Colgate-Palmolive's Q1 results exceeded Wall Street expectations, with revenue of $5.32 billion beating analyst estimates of $5.23 billion by 1.8%.
  • Adjusted EPS beat forecasts at $0.97 versus the estimated $0.94, representing a positive performance for investors.
  • CEO Noel Wallace highlighted that emerging markets have accelerated, driving broad-based growth across categories and geographies.
  • Successful interventions in the Hawley & Hazel business and continued investments in advertising are serving as key drivers of this momentum.
  • Sales volumes rose 1.1% year-on-year, indicating underlying consumer demand strength after a negative quarter the previous year.
  • Management confirmed that organic revenue grew by 2.9%, reinforcing positive sales performance despite margin headwinds.
  • Strong performance in key Asian markets like China and India is being supported by innovation, digital execution, and strategic resets.
Risk Factors
  • Operating margins contracted significantly, dropping from 21.9% last year to 18.1%, indicating persistent pressure on profitability.
  • The CFO highlighted a $300 million increase in costs driven by inflation in oil-based raw material inputs, creating margin headwinds that pricing and productivity must offset.
  • Management explicitly lowered expectations for gross margins for the full year despite efforts to mitigate cost pressures.
  • Volume growth in North America remains a key concern as it trails emerging markets, requiring a strategic reset to improve share gains.
  • The company faces sustained competition in the U.S. Oral Care segment and must work to regain lost market share.
  • Analysts are closely watching the sustainability of volume growth in emerging markets following accelerated but potentially cyclical performance.
Somewhat Bearish -25

Colgate-Palmolive: Too Expensive For A Defensive Firm

📉 Sales grew 8% while EPS dropped 6% in Q1 2026.

👎 Stock downgraded to "conservative hold" due to mixed performance.

🗺️ FX gains abroad mask structural weakness in North America.

💸 Rising costs and low consumer confidence create near-term headwinds.

📉 Colgate-Palmolive (CL) delivered 8% sales growth in Q1 2026, but earnings per share declined by 6%.

👎 Analysts have downgraded the stock to a "conservative hold" rating due to mixed performance.

📈 Organic revenue growth is estimated at just 2.9%, below total sales growth metrics.

🧴 North America sales are declining, driven by increased toothpaste competition and margin compression.

🌍 Foreign exchange (FX) tailwinds provided significant growth in Latin America, EMEA, and APAC regions.

⚠️ There is concern that the recent international growth may not be sustainable if currency trends reverse.

💸 Low U.S. consumer confidence and elevated input costs are creating near-term headwinds for the company.

🛢️ A specific $300 million impact from the Middle East is contributing to current cost pressures.

⚖️ The disconnect between strong top-line sales and weaker earnings suggests underlying profitability issues.

📊 Currency fluctuations in international markets are temporarily masking structural weakness in North American operations.

Bullish Signals
  • Colgate-Palmolive achieved 8% Q1 2026 sales growth.
  • Foreign exchange boosted growth in Latin America, EMEA, and APAC.
Risk Factors
  • EPS declined 6% despite sales growth due to profitability concerns.
  • Organic growth is weak at only 2.9%.
  • North American sales fall amid toothpaste competition.
  • Margin compression reduces overall profitability.
  • Growth relies on FX tailwinds with reversal risk.
  • Low U.S. confidence dampens discretionary product demand.
  • High input costs pressure margins and pricing.
Bullish Signals
  • Colgate-Palmolive delivered 8% sales growth in the first quarter of 2026, demonstrating resilient topline performance.
  • Foreign exchange tailwinds provided a significant boost to growth across Latin America, EMEA, and APAC regions.
Risk Factors
  • Despite an 8% total sales growth in Q1 2026, EPS declined by 6%, prompting a conservative hold rating due to underlying profitability concerns.
  • Organic growth is estimated at only 2.9%, indicating that headline sales figures are largely driven by external factors rather than core business performance.
  • North America sales are specifically falling due to increased toothpaste competition, which threatens the company's dominant domestic market position.
  • Margin compression in key markets reduces profitability even as top-line numbers appear healthy.
  • Significant growth in Latin America, EMEA, and APAC regions is driven by FX tailwinds, creating a risk that earnings will reverse if currency trends fluctuate.
  • Persistent low U.S. consumer confidence creates a macroeconomic headwind that could dampen demand for discretionary or semi-discretionary personal care products.
  • Elevated input costs pose a continued pressure on margins and pricing power.
Slightly Bullish +25

There May Be Some Bright Spots In Colgate-Palmolive's (NYSE:CL) Earnings

📊 Shares remained flat after weak earnings but revealed strong US$3.8b cash flow.

⚖️ One-off US$1.1b expenses caused profits to lag behind actual free cash generation.

🔮 Analysts expect higher future profits if unusual charges do not recur.

🛡️ Three specific risks identified, though high ROE and insider buying remain positive.

📊 Colgate-Palmolive shares showed limited market movement following the release of weak recent earnings reports.

💰 The company posted free cash flow of US$3.8b for the last twelve months, significantly exceeding its reported statutory profit of US$2.09b.

📉 A negative accrual ratio of -0.23 indicates that statutory earnings were substantially lower than the company's actual free cash generation.

⚖️ The disparity between paper profits and cash flow was partly driven by one-time unusual expenses totaling US$1.1b in the trailing twelve months.

🔮 Assuming these unusual non-cash charges do not recur, analysts expect Colgate-Palmolive to report higher statutory profits in the coming year.

📈 The negative accrual ratio suggests that current earnings figures may be conservative rather than indicative of poor underlying performance.

🛡️ Simply Wall St experts identify three specific investment risk warning signs associated with Colgate-Palmolive for investors to monitor.

🧠 Management's recent technology and quantum computing developments were mentioned as potential positive factors offsetting headline numbers.

📊 Interactive tools are available to visualize analyst forecasts for the company's future profitability trajectory.

⚠️ Investors should also consider metrics such as high return on equity and insider buying activity when evaluating the stock.

📝 This analysis is based on historical data and does not constitute a direct recommendation to buy or sell Colgate-Palmolive shares.

Bullish Signals
  • Free cash flow improved to US$3.8 billion.
  • Accrual ratio of -0.23 shows strong underlying cash generation.
  • One-time items of US$1.1 billion reduced recent profits.
  • Future earnings likely higher if non-recurring costs do not repeat.
Risk Factors
  • Colgate shares stalled after weak recent earnings.
  • Accrual ratio of -0.23 signals earnings below free cash flow.
  • US$1.1b profit cut by recurring unusual items risk.
  • High metrics may miss price-sensitive announcements.
Bullish Signals
  • Colgate-Palmolive's free cash flow improved over the last year, reaching US$3.8 billion compared to US$2.09 billion in profit.
  • The company recorded a negative accrual ratio of -0.23 for the year to March 2026, indicating that statutory earnings are significantly lower than actual free cash flow.
  • US$1.1 billion in unusual items reduced reported profit in the last twelve months; if these non-recurring expenses do not repeat, future profits are expected to be higher.
  • Management has maintained a conservative stance on statutory earnings due to these adjustments, suggesting underlying earnings potential may even exceed current reported figures.
Risk Factors
  • Colgate-Palmolive posted weak earnings recently, causing its shares to show little movement in the market.
  • The company reported an accrual ratio of -0.23 for the year to March 2026, indicating that statutory earnings were significantly less than free cash flow, partly due to unusual items.
  • In the last twelve months, Colgate-Palmolive's profit was reduced by unusual items worth US$1.1b, though there is a risk these expenses could recur.
  • Despite high return on equity and strong cash conversion, the article notes that such metrics may not account for the latest price-sensitive company announcements or qualitative material in their analysis.
Slightly Bullish +25

Investor News - Colgate-Palmolive Company

🗓 Executives present live at CAGNY Conference on Feb 20, 2026.

💻 View webcast slides and recordings via the Investor Center.

🏢 Company operates four segments: Oral, Personal, Home Care, Pet.

🌍 Products sold in over 200 countries under many brands.

💚 Core sustainability goals include waste reduction and water saving.

🗓️ Executives Noel Wallace and Caroline Chulick will present at the Consumer Analyst Group of New York Conference on Friday, February 20, 2026, at 8:00 am ET.

🖥️ Investors can access a live webcast and presentation slides via Colgate's website, with a recorded version available for later viewing through the Investor Center page.

🏢 Colgate-Palmolive operates as an innovative growth company focused on four main segments: Oral Care, Personal Care, Home Care, and Pet Nutrition.

🌍 The company sells its products in more than 200 countries and territories under well-known brands such as Colgate, Palmolive, Ajax, Hill's, Tom's of Maine, and many others.

💚 Sustainability is a core pillar of the company's strategy, with initiatives focused on decreasing plastic waste and promoting recyclability across its operations.

💧 Environmental efforts also include water-saving measures and improving children's oral health through the Colgate Bright Smiles, Bright Futures program.

👶 The Bright Smiles, Bright Futures initiative has reached approximately two billion children and their families since it launched in 1991.

Bullish Signals
  • Colgate-Palmolive leads sustainability with reduced plastic waste.
  • Program reached 2 billion children since 1991 for oral health.
Risk Factors
  • Lacks financial metrics, revenue guidance, or earnings data.
  • Ignores competitive pressures and market share risks.
Bullish Signals
  • Colgate-Palmolive is recognized for its leadership and innovation in promoting sustainability, including achievements in decreasing plastic waste and promoting recyclability.
  • The company's Colgate Bright Smiles, Bright Futures program has successfully reached approximately two billion children and their families since 1991 to improve children's oral health.
Risk Factors
  • No specific financial metrics, revenue guidance, or earnings data are provided in the announcement to assess current business performance.
  • The press release focuses almost exclusively on sustainability achievements and brand lists without addressing any competitive pressures or market share risks.
Slightly Bullish +25

Has The Recent Pullback Opened An Opportunity In Colgate-Palmolive (CL)?

📉 Stock dropped 4.2% this week but trades 32.1% below DCF intrinsic value.

💰 Current price is US$85.12 with a P/E of 32.0x, well above peers.

🛡 Strong brand manages costs and competition in emerging household product markets.

📉 Colgate-Palmolive (CL) has seen a share price decline of 4.2% over the last week and 10.5% over the past month.

💰 The current stock price is approximately US$85.12, while year-to-date returns remain positive at 9.6%.

📊 Long-term performance shows a 3-year return of 24.5% and a 5-year return of 20.9%.

⚖️ Simply Wall St's valuation checks give Colgate-Palmolive a score of 2 out of 6 based on their methodology.

💵 A Discounted Cash Flow (DCF) analysis estimates an intrinsic value of about US$125.40 per share.

📉 This implies the stock is trading at roughly a 32.1% discount compared to its DCF estimate.

🔢 Colgate-Palmolive currently trades at a P/E ratio of 32.0x.

🏭 This P/E is higher than the industry average of 16.4x and the peer group average of 22.1x.

🎯 Simply Wall St's proprietary Fair Ratio for the company is set at 27.8x earnings.

✍️ The article suggests using "Narratives" to connect personal investment stories with financial numbers for valuation.

📈 Analyst targets range from US$83 to US$106, allowing investors to model different future scenarios.

🛡️ Colgate-Palmolive is described as a large, globally recognized household products brand managing cost and competition.

⚠️ The article notes that recent weakness may be due to investors reassessing risk regarding consumer demand trends.

📝 Simply Wall St provides fundamental analysis driven by historical data and analyst forecasts only.

🚫 The report explicitly states it is not financial advice and does not constitute a recommendation to buy or sell.

🌐 The company operates in the Household Products sector with a focus on cost management and emerging markets.

📉 Recent coverage highlights attention on managing costs, competition in oral care, and broader consumer demand.

Bullish Signals
  • Share price recovered with 9.6% YTD despite volatility.
  • Strong underlying stability shows 24.5% (3-year) and 20.9% (5-year) returns.
  • DCF model values US$125.40, a 32.1% discount to current US$85.12.
  • Free cash flow projects growth from $3.58B to $4.10B by 2030.
  • Global brand leadership justifies premium 32.0x P/E vs 16.4x industry.
Risk Factors
  • Stock trades at 32.0x P/E versus fair estimate of 27.8x.
  • Analyst targets range from $83 to $106 vs current price of $85.12.
  • Rising costs and competition could pressure revenue growth and margins.
  • DCA valuation relies on assumptions about future cash flow reaching $4.10b.
Bullish Signals
  • Colgate-Palmolive's share price has recovered to a 9.6% year-to-date return despite recent short-term volatility, indicating underlying stability over longer periods of 24.5% (3-year) and 20.9% (5-year).
  • A Discounted Cash Flow model estimates an intrinsic value of US$125.40 per share, suggesting the current price of around US$85.12 represents a significant 32.1% discount to fair value.
  • The company is projecting free cash flow growth from $3.58 billion in the latest twelve months to an estimated $4.10 billion by 2030 based on analyst inputs and Simply Wall St extrapolations.
  • The current P/E ratio of 32.0x reflects a premium valuation compared to the industry average of 16.4x, which aligns with the company's strong growth prospects and market leadership as a globally recognized household brand.
Risk Factors
  • Colgate-Palmolive trades at a P/E ratio of 32.0x, which exceeds its proprietary Fair Ratio estimate of 27.8x and the industry average of 16.4x, suggesting the stock is priced on a multiple that analysts may not fully support.
  • Analyst consensus targets range from as low as $83 to $106, indicating significant uncertainty and disagreement among professionals regarding the company's fair value compared to the current price of around $85.12.
  • Recent coverage highlights risks such as rising costs, intensifying competition in oral care, and cautious consumer demand trends, which could pressure future revenue growth and margin expansion plans.
  • While a Discounted Cash Flow model estimates an intrinsic value of $125.40 based on 2030 projections, this valuation relies heavily on assumptions about future cash flow reaching $4.10b by 2030, leaving the stock vulnerable if cost programs or growth in emerging markets fail to materialize.
Somewhat Bullish +35

Is Wall Street Bullish or Bearish on Colgate-Palmolive Stock?

📊 CL holds a $68.5B market cap and integrates science-led AI innovation.

📈 Stock rose 9.3% YTD, beating the S&P 500's 5.2% gain.

🏆 Q1 revenue grew 8.4%, exceeding expectations with strong emerging market sales.

💰 Analysts project EPS growth to $3.83 for the current fiscal year.

⭐ Mean price target is $94.68, suggesting nearly 10% upside potential.

📊 Colgate-Palmolive (CL) trades at a $68.5 billion market cap and focuses on science-led innovation and AI integration.

📉 Shares of CL declined 4.9% over the past 52 weeks, underperforming the S&P 500 which gained 26.6%.

📈 However, YTD performance shows CL is up 9.3%, significantly outpacing the SPX's 5.2% rise.

⚠️ The stock has also lagged the State Street Consumer Staples Select Sector SPDR Fund (XLP) over the last year.

🏆 Q1 earnings were better than expected, with revenue growing 8.4% year-over-year to $5.3 billion.

💰 Adjusted EPS of $0.97 beat Wall Street consensus estimates of $0.95 for the quarter.

🌏 Management attributed growth to improved sales volumes and strong brand performance in emerging markets.

🤖 Analysts expect CL's EPS to grow 3.8% year-over-year to $3.83 for the current fiscal year ending in December.

📅 CL has topped consensus estimates in each of the last four quarters, demonstrating a promising earnings surprise history.

⭐ Among 21 analysts covering the stock, the consensus rating is "Moderate Buy" with nine suggesting "Strong Buy."

💡 The mean price target is $94.68, implying a 9.7% premium to current levels as of publication.

📈 The Street-high price target stands at $105, indicating up to 21.6% potential upside from current prices.

👤 DBS analyst Andy Sim maintained a "Hold" rating with a specific price target of $95.

Bullish Signals
  • Q1 revenue rose 8.4% YoY to $5.3 billion.
  • Adjusted EPS of $0.97 beat the $0.95 consensus.
  • Company topped estimates for four consecutive quarters.
  • Analysts project FY EPS growth of 3.8% to $3.83.
  • Nine of 21 analysts rate stock Strong Buy.
Risk Factors
  • Shares down 4.9% vs S&P 500's 26.6% gain.
  • Stock underperformed XLP sector fund with only 2.4% rise.
  • One analyst rates 'Strong Sell'; seven remain neutral 'Hold'.
  • Projected EPS growth of only 3.8% to $3.83.
Bullish Signals
  • On May 1, Colgate-Palmolive (CL) reported better-than-expected Q1 earnings with revenue increasing 8.4% year-over-year to $5.3 billion.
  • The company topped consensus estimates by $269 million per share, and its adjusted EPS of $0.97 surpassed Wall Street expectations of $0.95.
  • Management attributed strong performance to improved sales volumes and robust brand performance in emerging markets, particularly within the Asia Pacific region.
  • For the current fiscal year ending in December, analysts project CL's EPS will grow 3.8% year over year to reach $3.83.
  • Colgate-Palmolive has topped consensus estimates in each of the last four quarters, highlighting a consistent track record of beating expectations.
  • Of the 21 analysts covering the stock, nine suggest a 'Strong Buy' rating, marking an increase from the previous month and indicating rising bullish sentiment.
  • The Street-high price target of $105 implies a significant 21.6% potential upside from current price levels.
  • Analyst Andy Sim from DBS maintained a 'Hold' rating with a price target of $95, suggesting a 10% potential upside.
Risk Factors
  • Shares of Colgate-Palmolive (CL) have declined 4.9% over the past 52 weeks, significantly lagging behind the broader S&P 500 Index which gained 26.6% in the same period.
  • The stock has underperformed the State Street Consumer Staples Select Sector SPDR Fund (XLP), dropping relative to its peer group's 2.4% rise over the past year.
  • Among the 21 analysts covering the stock, one analyst holds a 'Strong Sell' rating, and seven maintain a neutral 'Hold' position rather than a bullish stance.
  • For the current fiscal year ending in December, analysts only project an EPS growth of 3.8% year over year to $3.83, suggesting limited upside potential compared to historical performance.
Slightly Bullish +25

Colgate-Palmolive Balances Growth Momentum With Margin Strain

📈 Organic sales grew 1%–4% driven by Hill's and emerging markets despite cost headwinds.

⚠️ Gross margins face pressure from high oil prices and logistics costs requiring innovation to offset.

💡 Management maintains EPS guidance amid macro uncertainty and a $300M one-time cost impact.

💼 Colgate-Palmolive reported Q1 2026 results with robust top- and bottom-line expansion while maintaining an upbeat yet cautious outlook for the full year.

📈 Organic sales growth improved sequentially in Q1, with management reaffirming a full-year guidance of 1% to 4% driven by strong Hill's performance and emerging markets.

🐾 Hill's pet care was a standout performer, posting approximately 4.8% organic growth excluding the strategic exit from the private-label pet food category.

🌏 Emerging markets served as the primary growth engine, with mid-single-digit growth in Latin America led by Mexico and Brazil, and contributions from China and India.

🔥 The company expanded its Strategic Productivity Program to target $200 million to $300 million in savings expected to materialize between 2027 and 2028.

💰 Management increased spending on advertising, innovation, and AI capabilities to improve returns and sustain pricing power despite rising input costs.

📉 Surging raw-material and logistics costs have forced a revision of the gross margin outlook, with management now expecting margins to decline year-over-year for the full year.

🛢️ Cost pressures are primarily driven by higher oil prices (assumed at $110/barrel), causing spending on oil-linked inputs like resins and fats/oils to rise over 20%.

🚛 Logistics costs are projected to climb nearly 10% due to inflation, further squeezing margins alongside commodity price increases.

📍 North America underperformed other regions in Q1 due to volume declines from shelf resets, delayed shipments, and tariff-related pressure on gross margins.

🔀 The exit from private-label pet food created a 260 basis-point drag in Q1, which is expected to shrink significantly as the transition clears by the back half of 2026.

⚠️ Management cited broader macro uncertainty, including consumer spending patterns and interest rates, alongside oil prices and weak dry dog segments as potential risks.

📊 Despite the cost shock of roughly $300 million identified since Q4, Colgate reiterated its full-year guidance for 1%–4% organic sales and low-to-mid single-digit EPS growth.

💡 Innovation-linked pricing was highlighted by management as a key lever to offset inflation shocks and maintain product mix profitability in the near term.

🛠️ The Strategic Productivity Program is viewed as a medium-term margin lever that will conclude by the end of 2028, offering relief against structural cost inflation.

Bullish Signals
  • Q1 2026: Robust expansion across all key profit metrics.
  • Organic sales growth improved sequentially versus Q4.
  • Full-year organic sales outlook reaffirmed at 1% to 4%.
  • Hill's posted 4.8% organic growth excluding private label.
  • Emerging markets drove mid-single-digit Latin America growth.
  • Productivity program targets $200M-$300M in total savings.
  • Tariff pressures expected to normalize over the year.
Risk Factors
  • Raw-material and freight inflation could exceed 20% and 10%, squeezing margins.
  • Gross margins now expected to decline year over year.
  • $300 million in additional 2026 costs force cautious margin trajectory.
  • $110 oil/barrel assumption drives resin and fat input inflation.
  • North America volume/mix underperformance and tariff pressure weigh on results.
  • Sluggishness in China amid macro uncertainty and weak spending.
  • Private-label pet food exit creates 260 bps Q1-Q2 performance drag.
  • Higher ad/AI spending increases cash burn, offsetting profitability gains.
Bullish Signals
  • Colgate-Palmolive reported robust top- and bottom-line expansion in Q1 2026, delivering simultaneous gains in gross profit, operating income, EPS, and free cash flow.
  • Organic sales growth improved sequentially versus Q4, reinforcing management's belief that underlying demand remains healthy despite challenging category trends.
  • The company reaffirmed its full-year organic sales outlook of 1% to 4%, indicating current momentum is broadly tracking internal expectations without needing to downgrade guidance.
  • Hill's continued to be a significant bright spot, posting about 4.8% organic growth excluding private label, with the U.S. segment growing roughly 5% as consumers trade up to premium offerings.
  • Emerging markets served as a primary growth engine, with Mexico and Brazil driving mid-single-digit growth in Latin America to offset softer trends in mature regions.
  • Specific geographic contributors included China and India in Asia Pacific, underscoring the durability of earnings power across key international divisions.
  • Management expanded its strategic productivity program, now targeting $200 million to $300 million in savings over the life of the plan to offset cost pressures.
  • Most benefits from the productivity program are expected to materialize in 2027 and 2028, providing a clear medium-term margin lever for future profitability.
  • Management is increasing spending on advertising, omnichannel demand generation, innovation, and data/AI capabilities, pointing to improving returns on higher ad outlays.
  • The strategic exit from private-label pet food created a one-time headwind but is expected to shrink to 20–30 basis points in Q2 and largely fade by the back half of the year.
  • Management expects tariff-related pressure in North America to normalize as the year progresses, which should ease regional margin drag over time.
Risk Factors
  • Surging input and logistics costs, specifically with raw-material and freight inflation expected to climb more than 20% and nearly 10% respectively, will squeeze gross margins this year.
  • Management now expects gross margins to decline year over year instead of improving due to commodity and freight inflation outpacing pricing and productivity gains.
  • Colgate identified approximately $300 million in additional raw-materials and logistics costs for 2026, forcing a revision to a more cautious gross-margin trajectory.
  • The company is assuming oil prices around $110 per barrel for the rest of the year, which significantly drives cost inflation for resin, petrochemical, and fat/oil inputs.
  • North America remains a weak spot where volume and mix underperformance are weighing on overall results alongside notable tariff-related pressure.
  • Sluggishness persists in some categories and markets, including parts of China, against a backdrop of broader macro uncertainty and consumer spending patterns.
  • The strategic exit from private-label pet food created a 260 basis-point drag on company performance in Q1, though this headwind is expected to persist through Q2.
  • Higher spending on advertising, innovation, and data/AI capabilities increases near-term cash burn, offsetting some of the immediate profitability gains.
Bullish +70

JPMorgan Lifts Colgate Price Target to $96: Why Emerging Markets Are Powering the Defensive Trade

📈 JPMorgan raised the price target to $96 with an Overweight rating.

🌍 Emerging markets drove 6% organic sales growth, led by Latin America.

💰 EPS beat estimates for the fourth consecutive quarter.

🤴 The company maintains Dividend King status with 60 years of increases.

⚠️ Risks include tariffs, FX translation, and potential defensive rotation.

📈 JPMorgan raised its price target for Colgate-Palmolive (CL) from $95 to $96 while maintaining an Overweight rating.

🌍 The upgrade is driven by the company's strong exposure to faster-growing emerging markets compared to staples peers focused on developed economies.

📅 Following a robust Q1 2026, the firm reported emerging markets organic sales growth of 6% and volume growth of 4%.

📈 Latin America led sales with a 15% increase, while Asia Pacific posted the strongest organic growth at 6%.

💰 Colgate-Palmolive's adjusted EPS of $0.97 beat the consensus of $0.94 for the fourth consecutive quarter.

🤴 The company holds a "Dividend King" status with over 60 consecutive years of dividend increases, appealing to income investors.

📊 Operating in over 200 countries, Colgate maintains a 41% global share of the toothpaste market and a diverse brand portfolio.

🌎 CEO Noel Wallace highlighted strong top and bottom-line growth across the broad business at the start of 2026.

⚠️ Risks include tariff headwinds that led management to revise full-year gross margin guidance downward.

📉 North America organic sales declined by 2%, contrasting with performance in other global regions.

💵 The stock trades around $85.80 with a forward P/E of 23x, though some analysts note this presents rich valuation risks.

📉 Current analyst consensus price target sits at $95.53, placing JPMorgan's new target slightly above the average.

📉 Hill's Pet Nutrition contributed positively with 7% revenue growth following its Prime100 acquisition.

📈 Shares have risen approximately 8% year-to-date as investors seek defensive names amidst AI-driven market volatility.

⚠️ Bearish concerns focus on foreign exchange translation risks, slowing volumes, and the potential for rotation out of defensives if AI leadership resumes.

👀 Investors should monitor Q2 2026 results for sustained organic growth in emerging markets to validate JPMorgan's bullish thesis.

Bullish Signals
  • JPMorgan raised target to $96 with Overweight rating.
  • Q1 EPS beat of $0.97 marks fourth consecutive win.
  • Asia sales grew 6%; Latin America up 15%.
  • Dividend king status with over 60 years of increases.
  • Holds 41% global toothpaste share in 200+ countries.
  • Hill's revenue rose 7% after Prime100 acquisition.
  • Shares up 8% YTD as defensive staple.
Risk Factors
  • Tariff headwinds compressed full-year gross margin guidance.
  • North America organic sales declined by 2%.
  • High P/E of 33x limits multiple expansion potential.
  • Foreign exchange risk threatens near-term reported earnings.
  • Slowing developed market volumes hurt organic growth.
Bullish Signals
  • JPMorgan lifted Colgate-Palmolive's price target to $96 from $95 while maintaining its Overweight rating.
  • The company delivered a strong Q1 2026 beat with adjusted EPS of $0.97, beating the $0.94 consensus and marking the fourth consecutive EPS beat.
  • Emerging markets are driving growth with organic sales growth of 6% in Asia Pacific and net sales up 15% in Latin America.
  • Colgate-Palmolive is a dividend king with over 60 consecutive years of dividend increases, offering a yield around 2% for income investors.
  • The company holds a dominant global toothpaste share of 41% and operates across 200+ countries and territories.
  • Hill's Pet Nutrition contributed positively with +7% revenue following the Prime100 acquisition.
  • Shares are up 8% year to date, reflecting investor appetite for defensive staples amid market volatility.
Risk Factors
  • Colgate-Palmolive management revised full-year gross margin guidance downwards citing significant tariff headwinds, which could compress profitability despite recent earnings beats.
  • North America organic sales declined by 2%, indicating potential weakness in the company's largest market following its defensive trade momentum.
  • The stock currently trades at a premium valuation with a trailing P/E of 33x and forward P/E of 23x, limiting potential for multiple expansion even if growth holds.
  • Significant foreign exchange (FX) translation risk remains a key downside factor that could negatively impact reported revenue and earnings in the near term.
  • Slowing staples volumes in developed markets pose a threat to organic growth rates, particularly as the defensive trade may rotate out if AI infrastructure leadership resumes.
Neutral +3

Colgate-Palmolive Warns Of $300m Cost Hit From Middle East Conflict

📈 Shares rose 3% after Colgate beat sales and profit expectations.

⚠️ Geopolitical tensions drive an extra $300M in costs for the year.

💰 Management will raise prices via premium products to protect margins.

🔧 Operations simplification targets $200M–$300M in savings by 2027/2028.

🌍 Global volumes grew slightly as strong international performance offset US weakness.

📈 Colgate-Palmolive shares rose 3% in early trading on Friday (1 May) after beating first-quarter sales and profit expectations.

⚠️ The company expects an additional $300 million (€255.97 million) in raw material and logistics costs for the year due to the Middle East conflict.

📦 Rising commodity prices and disrupted supply chains from the US-Iran conflict are increasing expenses for Colgate and its rivals like Unilever and P&G.

💰 Management plans to continue raising prices, primarily through new premium products, to protect margins amid higher input costs.

🔧 The cost-savings programme aimed at simplifying operations by 2028 is expected to generate $200 million–$300 million in savings, mostly from 2027.

🛒 Quarterly net sales reached $5.32 billion (€4.54 billion), exceeding the average analyst estimate of $5.22 billion (€4.45 billion).

📊 Adjusted earnings per share came in at 97 cents, surpassing the consensus estimate by 2 cents.

🌍 Demand for oral, personal care, and household products remained steady globally despite price hikes, particularly in international and emerging markets.

🇺🇸 Weak sales in the US segment were countered by stronger performance abroad as consumers opted for value-driven alternatives.

📉 North America volumes fell 3.2% in the quarter while overall global volumes increased slightly by 1.1%.

💹 Overall pricing increased by 2.2% during the quarter, with most benefits realized through premium product launches.

🤔 TD Cowen analysts noted that Colgate was cautious about price increases given consumers' current value-conscious sentiment.

📉 The company reaffirmed its annual sales and profit forecasts but warned of persistent volatility in macroeconomic conditions.

⏳ Management cautioned that slower category growth is likely to persist into 2026 due to the geopolitical situation.

💸 Higher logistics expenses are expected to weigh on global consumer spending power, potentially limiting future demand growth.

Bullish Signals
  • Shares rose 3% after beating sales and profit expectations.
  • Quarterly net sales reached $5.32 billion, surpassing estimates.
  • Adjusted EPS of 97 cents exceeded analyst forecasts.
  • Demand remained steady despite price hikes globally.
  • Overall volumes increased 1.1% despite North America declines.
Risk Factors
  • Middle East conflict adds $300M in raw material and logistics expenses.
  • TD Cowen caution cites consumer value-consciousness against price increases.
  • North America volume sales fell 3.2% due to demand decline.
  • Macroeconomic volatility and slow growth create revenue uncertainty through 2026.
  • Rising costs may further dampen global spending on everyday products.
Bullish Signals
  • Shares rose 3% in early trading on Friday (1 May) after the company beat first-quarter sales and profit expectations.
  • Colgate reported quarterly net sales of $5.32 billion, exceeding average analysts' expectations of $5.22 billion.
  • Adjusted earnings per share of 97 cents surpassed estimates by 2 cents, demonstrating strong underlying profitability.
  • Demand for Colgate's oral, personal care and household products remained steady despite price hikes, especially in its international and emerging markets segments.
  • Overall volumes inched up 1.1% for the quarter, offsetting volume declines in the North America segment which fell 3.2%.
  • Colgate is executing a cost-savings programme aimed at simplifying operations by 2028, expected to generate $200 million-$300 million in savings starting in 2027.
Risk Factors
  • Colgate-Palmolive faces an additional $300 million in raw material and logistics expenses for the year due to the Middle East conflict, joining other global companies in warning of significant cost pressures.
  • Analysts from TD Cowen express caution regarding the company's strategy of raising prices, noting that consumers are becoming increasingly value-conscious in the current economic climate.
  • Volume sales in the North America segment fell 3.2% in the quarter, indicating a decline in demand even though overall global volumes and pricing saw slight increases.
  • The company warned that volatile macroeconomic conditions and slower category growth are likely to persist into 2026, creating uncertainty about future revenue streams.
  • Rising costs for raw materials, packaging, and logistics could weigh on global consumer spending, potentially further dampening demand for everyday products.